Drug pricing in America : a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session.

Format:

Book

Government document

Author/Creator:

United States. Congress. Senate. Committee on Finance, author.

Series:

United States. Congress. Senate. S. hrg.

S. hrg. ; 116-267

Language:

English

Subjects (All):

Drugs--Prices--Government policy--United States.

Drugs.

Prescription pricing--United States.

Prescription pricing.

Drugs--United States--Cost control.

Pharmaceutical industry--United States.

Pharmaceutical industry.

Drugs--Cost control.

Drugs--Prices--Government policy.

United States.

Genre:

Legislative hearings.

Physical Description:

1 online resource (volumes).

Place of Publication:

Washington : U.S. Government Publishing Office, 2019-

Participant:

"Hearing witnesses: Miller, Steve, M.D., executive vice president and chief clinical officer, Cigna Corporation, Bloomfield, CT; Rice, Derica, executive vice president, CVS Health; and president, CVS Caremark, Woonsocket, RI; Fleming, William K., Pharm.D., segment president, healthcare services, Humana, Inc., Louisville, KY; Prince, John M., chief executive officer, OptumRx, Minnetonka, MN; Kolar, Mike, interim president and CEO, Prime Therapeutics, LLC, Eagan, MN."--Pt. 3.

"Hearing witnesses: Sego, Kathy, mother of a child with insulin-dependent diabetes, Madison, IN; Holtz-Eakin, Douglas, Ph.D., president, American Action Forum, Washington, DC; Miller, Mark, Ph.D., executive vice president of health care, Laura and John Arnold Foundation, Houston, TX; Bach, Peter B., M.D., director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, NY."--Pt. 1.

Notes:

Access ID (govinfo): CHRG-116shrg41359.

"Serial no. 116-267"--Pt. 1.

"January 29, 2019"--Pt. 1.

"February 26, 2019"--Pt. 2.

"Serial no. 116-39"--Pt. 2.

"April 9, 2019"--Pt. 3.

"Serial no. 116-415"--Pt. 3.

Includes bibliographical references.

Date of hearing: 2019-01-29--Pt. 1.

Date of hearing: 2019-04-09--Pt. 3.

Description based on online resource; title from PDF, pt. 2, title page (govinfo, viewed Aug. 12, 2019).

Other Format:

Print version: United States. Congress. Senate. Committee on Finance. Drug pricing in America

Microfiche version: United States. Congress. Senate. Committee on Finance. Drug pricing in America

OCLC:

1112073384

Publisher Number:

41-359 (GPO jacket number)